Piper Jaffray Warns on Recent Contract Action for MedAssets (MDAS); Shares Moving Lower
MDAS Hot Sheet
Rating Summary:8 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Shares of MedAssets (Nasdaq: MDAS) might be trading lower on the heels of a concerning research note from Piper Jaffray's Sean Wieland Monday morning. The stock last traded at $11.71, down about 1.8 percent from Friday's close.
Wieland warned recent failures to win three high-profile contracts may end up putting pressure on sales within its GPO segment.
The firm maintains an Underweight rating and $10 price target on shares of MedAssets.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Wieland warned recent failures to win three high-profile contracts may end up putting pressure on sales within its GPO segment.
The firm maintains an Underweight rating and $10 price target on shares of MedAssets.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Lazard Starts ATHN, CERN, QSII, MDAS at Buy, MDRX, OMCL, CPSI, EHTH at Neutral, EPOC at Sell
- Barclays Acknowledges Positive Q4 Results From Ralph Lauren (RL); Expect FY13 To Face Several Top Line Headwinds
- Barclays Maintains an 'Overweight' on Camelot Information Systems (CIS); Q1 Trends Mostly In-line
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
